Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

425.12
Delayed Data
As of Jul 29
 +14.08 / +3.43%
Today’s Change
329.09
Today|||52-Week Range
605.93
-21.69%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2015
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Revenue and IncomeNet Revenues998.6M1.1B1.1B1.2B
 
 
 
 
 
Cost of Goods Sold88.8M109.1M110.8M111.8M
 
 
 
 
 
Depreciation And Amortization15.3M20.7M22.9M23.0M
 
 
 
 
 
 
Operating ExpensesGross Income894.5M1.0B964.3M1.1B
 
 
 
 
 
General Expenses549.6M615.2M756.2M736.8M
 
 
 
 
 
Research And Development375.0M405.3M461.2M447.1M
 
 
 
 
 
Total Operating Expenses653.8M745.0M889.9M871.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income344.9M392.4M208.2M329.3M
 
 
 
 
 
Extraordinary Charge-16.0M-21.0K-1.9M0.00
 
 
 
 
Interest Expense On Debt2.7M1.7M3.6M1.4M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income328.0M393.3M227.3M330.2M
 
 
 
 
 
Income Taxes-133.4M-182.9M-72.3M-164.4M
 
 
 
 
 
Net Income194.6M210.4M155.0M165.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS102.9M103.3M103.8M104.3M
 
 
 
 
 
Shares To Calculate EPS Diluted115.3M115.9M115.5M114.2M
 
 
 
 
 
 
Earnings Per ShareEPS$1.69$1.82$1.34$1.45
 
 
 
 
 
EPS Diluted$1.69$1.82$1.34$1.45